S100A2 and head and neck squamous cell carcinoma: S100A2 transfection in melanoma cells revealed its anti-proliferative activity [15], in gastric cancer cells it seems to decrease cell invasiveness [16], and similarly in head and neck squamous cell carcinoma S100A2 reduces proliferation, cell motility and cancer cell invasion [17].